JX LUXVENTURE LTD (JXJT)

MHY460023028 - Common Stock

0.8321  -0.01 (-1%)

After market: 0.8006 -0.03 (-3.79%)

Fundamental Rating

5

JXJT gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 50 industry peers in the Textiles, Apparel & Luxury Goods industry. While JXJT has a great health rating, its profitability is only average at the moment. JXJT has a expensive valuation and it also scores bad on growth.



4

1. Profitability

1.1 Basic Checks

In the past year JXJT was profitable.
JXJT had a negative operating cash flow in the past year.
In the past 5 years JXJT reported 4 times negative net income.
In the past 5 years JXJT always reported negative operating cash flow.

1.2 Ratios

JXJT has a better Return On Assets (24.79%) than 98.00% of its industry peers.
Looking at the Return On Equity, with a value of 35.86%, JXJT belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
JXJT has a Return On Invested Capital of 28.35%. This is amongst the best in the industry. JXJT outperforms 94.00% of its industry peers.
Industry RankSector Rank
ROA 24.79%
ROE 35.86%
ROIC 28.35%
ROA(3y)-178.22%
ROA(5y)-108.78%
ROE(3y)-232.62%
ROE(5y)-141.69%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

JXJT has a better Profit Margin (10.18%) than 88.00% of its industry peers.
With a decent Operating Margin value of 10.19%, JXJT is doing good in the industry, outperforming 74.00% of the companies in the same industry.
With a Gross Margin value of 16.29%, JXJT is not doing good in the industry: 92.00% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of JXJT has grown nicely.
Industry RankSector Rank
OM 10.19%
PM (TTM) 10.18%
GM 16.29%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.54%
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so JXJT is creating value.
Compared to 1 year ago, JXJT has less shares outstanding
The number of shares outstanding for JXJT has been increased compared to 5 years ago.
JXJT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

JXJT has an Altman-Z score of -0.35. This is a bad value and indicates that JXJT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.35, JXJT is doing worse than 86.00% of the companies in the same industry.
JXJT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.35
ROIC/WACC3.76
WACC7.54%

2.3 Liquidity

JXJT has a Current Ratio of 2.88. This indicates that JXJT is financially healthy and has no problem in meeting its short term obligations.
JXJT's Current ratio of 2.88 is fine compared to the rest of the industry. JXJT outperforms 72.00% of its industry peers.
A Quick Ratio of 2.88 indicates that JXJT has no problem at all paying its short term obligations.
The Quick ratio of JXJT (2.88) is better than 92.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.88
Quick Ratio 2.88

3

3. Growth

3.1 Past

JXJT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 101.24%, which is quite impressive.
The Revenue for JXJT has decreased by -59.37% in the past year. This is quite bad
Measured over the past years, JXJT shows a quite strong growth in Revenue. The Revenue has been growing by 11.42% on average per year.
EPS 1Y (TTM)101.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.09%
Revenue 1Y (TTM)-59.37%
Revenue growth 3Y187.49%
Revenue growth 5Y11.42%
Sales Q2Q%-60.13%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 0.97, the valuation of JXJT can be described as very cheap.
JXJT's Price/Earnings ratio is rather cheap when compared to the industry. JXJT is cheaper than 100.00% of the companies in the same industry.
JXJT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.77.
Industry RankSector Rank
PE 0.97
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JXJT is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.82

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

JXJT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

JX LUXVENTURE LTD

NASDAQ:JXJT (12/18/2024, 4:30:02 PM)

After market: 0.8006 -0.03 (-3.79%)

0.8321

-0.01 (-1%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.04M
Analysts
Price Target
Short Float %
Short Ratio
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 0.97
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 24.79%
ROE 35.86%
ROCE
ROIC
ROICexc
ROICexgc
OM 10.19%
PM (TTM) 10.18%
GM 16.29%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.43
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.88
Quick Ratio 2.88
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)101.24%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-59.37%
Revenue growth 3Y187.49%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y